Prostaglandin E2-EP4 Receptor Promotes Endothelial Cell Migration via ERK Activation and Angiogenesis in Vivo
Open Access
- 1 June 2007
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 282 (23), 16959-16968
- https://doi.org/10.1074/jbc.m701214200
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survivalOncogene, 2006
- Lack of Expression of the EP2 but not EP3 Receptor for Prostaglandin E2 Results in Suppression of Skin Tumor DevelopmentCancer Research, 2005
- Differential Regulation of Phosphorylation of the cAMP Response Element-Binding Protein after Activation of EP2and EP4Prostanoid Receptors by Prostaglandin E2Molecular Pharmacology, 2005
- Colon Carcinoma Cell Growth Is Associated with Prostaglandin E2/EP4 Receptor-evoked ERK ActivationJournal of Biological Chemistry, 2004
- Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapySeminars in Oncology, 2004
- EP2 and EP4 prostanoid receptor signalingLife Sciences, 2003
- Prostaglandin E2 Induced Functional Expression of Early Growth Response Factor-1 by EP4, but Not EP2, Prostanoid Receptors via the Phosphatidylinositol 3-Kinase and Extracellular Signal-regulated KinasesJournal of Biological Chemistry, 2003
- Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor GrowthThe Journal of Experimental Medicine, 2003
- Prostanoid Receptors: Subtypes and SignalingAnnual Review of Pharmacology and Toxicology, 2001
- The Contributions of Cyclooxygenase-2 to Tumor AngiogenesisCancer and Metastasis Reviews, 2000